Developing and Optimizing Innovative Tools to Address Familial Hypercholesterolemia Underdiagnosis: Identification Methods, Patient Activation, and Cascade Testing for Familial Hypercholesterolemia

BACKGROUND: Familial hypercholesterolemia (FH) is the most common cardiovascular genetic disorder and, if left untreated, is associated with increased risk of premature atherosclerotic cardiovascular disease, the leading cause of preventable death in the United States. Although FH is common, fatal,...

Descripción completa

Detalles Bibliográficos
Autores principales: Campbell-Salome, Gemme, Jones, Laney K., Masnick, Max F., Walton, Nephi A., Ahmed, Catherine D., Buchanan, Adam H., Brangan, Andrew, Esplin, Edward D., Kann, David G., Ladd, Ilene G., Kelly, Melissa A., Kindt, Iris, Kirchner, H. Lester, McGowan, Mary P., McMinn, Megan N., Morales, Ana, Myers, Kelly D., Oetjens, Matthew T., Rahm, Alanna Kulchak, Schmidlen, Tara J., Sheldon, Amanda, Simmons, Emilie, Snir, Moran, Strande, Natasha T., Walters, Nicole L., Wilemon, Katherine, Williams, Marc S., Gidding, Samuel S., Sturm, Amy C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Methods Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7892261/
https://www.ncbi.nlm.nih.gov/pubmed/33480803
http://dx.doi.org/10.1161/CIRCGEN.120.003120

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7892261/
https://www.ncbi.nlm.nih.gov/pubmed/33480803
http://dx.doi.org/10.1161/CIRCGEN.120.003120

Ejemplares similares